Readmission rates Reduction –  reducing heart failure patients readmissions

 

 Readmission Reduction NI Medical  is a leading biotechnology company, and the  developer  of a whole body bioimpedance systems. Our non invasive cardiac output system has the  potential to help in Readmission Reduction. By using our technology we can assist in the assessment and management of residents with CHF ( Chronic heart failure) in  nursing home settings.

 Readmission Reduction of cardiac heart patients with Nicas

Heart failure is a syndrome of inadequate delivery of oxygen and nutrients to the tissues of the body, which can be due to a pumping or a relaxing problem of the heart. Many different cardiac disease states will present with heart failure. Heart failure affects  millions of people in the USA , with more then  700,000 new cases every year. The majority of admissions to the hospital for heart failure are, in fact, readmissions for heart failure. Approximately 24 percent of the people discharged from the hospital with heart failure will be readmitted within 30 days and more the half of them will be readmitted within 6 months. Heart failure is the number one Medicare discharge diagnosis and the direct and indirect costs of heart failure are about $40 billion annually.

Reducing heart failure Readmission rates with the NI-MEDICAL system